haemophilus b conjugate vaccine ( meningococcal protein conjugate ) , pedvaxhib ( prp-ompc ) , is a conjugate h influenzae type b vaccine developed at merck sharp & dohme research laboratories that now is undergoing extensive clinical evaluation to assess its prospects for disease control when first administered in early infancy .
C0717811
haemophilus b conjugate vaccine
C0722529
pedvaxhib